SAN

85.82

-0.54%↓

MRK1

115.55

0%↓

ARGX

791.2

-0.73%↓

PHIA

24.28

+0.08%↑

ONC.US

340.64

+1.61%↑

SAN

85.82

-0.54%↓

MRK1

115.55

0%↓

ARGX

791.2

-0.73%↓

PHIA

24.28

+0.08%↑

ONC.US

340.64

+1.61%↑

SAN

85.82

-0.54%↓

MRK1

115.55

0%↓

ARGX

791.2

-0.73%↓

PHIA

24.28

+0.08%↑

ONC.US

340.64

+1.61%↑

SAN

85.82

-0.54%↓

MRK1

115.55

0%↓

ARGX

791.2

-0.73%↓

PHIA

24.28

+0.08%↑

ONC.US

340.64

+1.61%↑

SAN

85.82

-0.54%↓

MRK1

115.55

0%↓

ARGX

791.2

-0.73%↓

PHIA

24.28

+0.08%↑

ONC.US

340.64

+1.61%↑

Kodu・Aktsiate loetelu・Nanobiotix

N
Nanobiotix

Suletud

17.5 3.18

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

Max

18.34

Põhinäitajad
By Trading Economics
Sissetulek	-46M
Müük	-21M
Kasumimarginaal	221.361
Töötajad	103
EBITDA	-44M

Soovitused
By TipRanks
Soovitused	Tugev "osta" hinnang
12 kuu keskmine prognoos	+27.49% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	2. dets 2025

Turustatistika
By TradingEconomics
Turukapital	907M
Eelmine avamishind	14.32
Eelmine sulgemishind	17.5

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bullish Evidence

2.975 / 3.015 Toetus ja vastupanu

Nanobiotix Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

26. nov 2025, 17:44 UTC

Tulu

Suurimad hinnamuutused turgudel

Deere Warns of Tough Year Ahead as Earnings, Sales Fall -- Update

27. nov 2025, 00:00 UTC

Market Talk

Rio Tinto's Coming Investor Briefing Seen Focused on Costs, Lithium, Asset Sales -- Market Talk

26. nov 2025, 23:47 UTC

Market Talk

Nikkei May Rise as Fears About Potential AI Bubble Ease -- Market Talk

26. nov 2025, 23:28 UTC

Market Talk

Mortgage Refinancing in New Zealand Will Spur Recovery -- Market Talk

26. nov 2025, 23:21 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

26. nov 2025, 23:21 UTC

Market Talk

RBNZ Rate Cuts Finally Getting Traction With Consumers -- Market Talk

26. nov 2025, 23:02 UTC

Market Talk

Steelmaking Coal Price Signal Knocked by China Import Shift -- Market Talk

26. nov 2025, 21:38 UTC

Tulu

These Stocks Moved the Most Today: Alphabet, Nvidia, AMD, Apple, Dell, Robinhood, Deere, HP Inc., Urban Outfitters, and More -- Barrons.com

26. nov 2025, 21:25 UTC

Tulu

Li Auto Posts Surprise Loss, Stock Rises. What's Next for Its Diving EV Sales. -- Barrons.com

26. nov 2025, 21:17 UTC

Omandamised, ülevõtmised, äriostud

Commercial Metals Co Announces Closing of $2B Senior Notes Offering

26. nov 2025, 21:16 UTC

Tulu

Deere Beat Earnings Estimates. Why the Stock Is Falling. -- Barrons.com

26. nov 2025, 21:09 UTC

Tulu

Roblox Isn't Playing Games. Why the Stock Could -2-

26. nov 2025, 21:09 UTC

Tulu

Roblox Isn't Playing Games. Why the Stock Could Jump 50%. -- Barrons.com

26. nov 2025, 20:27 UTC

Omandamised, ülevõtmised, äriostud

Charter Communications Stock Is a Disaster. The Answer Could Be a 10% Dividend. -- Barrons.com

26. nov 2025, 20:25 UTC

Omandamised, ülevõtmised, äriostud

Charter Communications Stock Is a Disaster. The Answer Could Be a 10% Dividend. -- Barrons.com

26. nov 2025, 20:15 UTC

Tulu

These Stocks Are Moving the Most Today: Alphabet, Nvidia, AMD, Apple, Dell, Robinhood, Deere, HP Inc., Urban Outfitters, and More -- Barrons.com

26. nov 2025, 20:08 UTC

Market Talk

Oil Futures Settle Higher in Choppy Trade -- Market Talk

26. nov 2025, 20:06 UTC

Market Talk

U.S. Natural Gas Settles Higher Ahead of Holiday -- Market Talk

26. nov 2025, 19:30 UTC

Tulu

These Stocks Are Moving the Most Today: Alphabet, Nvidia, AMD, Apple, Dell, Robinhood, Deere, HP Inc., Urban Outfitters, and More -- Barrons.com

26. nov 2025, 19:21 UTC

Omandamised, ülevõtmised, äriostud

Teck Resources: ISS and Glass Lewis Recommend Teck Hldrs Vote for Anglo American Deal

26. nov 2025, 18:43 UTC

Market Talk

U.S. Natural Gas Storage Down for Second Straight Week -- Market Talk

26. nov 2025, 18:41 UTC

Market Talk

U.S. Oil Rig Count Falls By 12 to 407 -- Market Talk

26. nov 2025, 18:19 UTC

Tulu

Workday Beat Earnings Estimates. The Stock Is Down 10% Anyway. -- Barrons.com

26. nov 2025, 17:51 UTC

Tulu

Deere Forecasts Higher Tariff Costs, Less Profit in 2026 -- WSJ

26. nov 2025, 17:50 UTC

Tulu

These Stocks Are Moving the Most Today: Alphabet, Nvidia, AMD, Apple, Dell, Robinhood, Deere, HP Inc., Urban Outfitters, and More -- Barrons.com

26. nov 2025, 17:20 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

Energy & Utilities Roundup: Market Talk

26. nov 2025, 17:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

26. nov 2025, 17:20 UTC

Market Talk

Health Care Roundup: Market Talk

26. nov 2025, 17:16 UTC

Tulu

Omandamised, ülevõtmised, äriostud

Blue Owl Is Having a Rough Year. Its Co-CEO Says -2-

26. nov 2025, 17:16 UTC

Tulu

Omandamised, ülevõtmised, äriostud

Blue Owl Is Having a Rough Year. Its Co-CEO Says Investors' Fears Are 'Ungrounded.' -- Barrons.com

Võrdlus sarnastega

Hinnamuutus

Nanobiotix Prognoos

Hinnasiht

By TipRanks

27.49% tõus

12 kuu keskmine prognoos

Keskmine 23 EUR 27.49%

Kõrge 25 EUR

Madal 21 EUR

Põhineb 3 Wall Streeti analüütiku instrumendi Nanobiotix 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

3 ratings

Osta

Hoia

Müü

Põhineb 3 analüütiku instrumendi Nanobiotix aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

2.975 / 3.015Toetus ja vastupanu

Recent bullish events outweigh bearish events.

Bearish events outweigh bullish events.

There is one bearish event.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Nanobiotix

Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is headquartered in Paris, France.